HEOYX
Price
$17.32
Change
-$0.13 (-0.74%)
Updated
Sep 20 closing price
RWIBX
Price
$66.87
Change
-$0.15 (-0.22%)
Updated
Sep 20 closing price
Ad is loading...

HEOYX vs RWIBX

Header iconHEOYX vs RWIBX Comparison
Open Charts HEOYX vs RWIBXBanner chart's image
Hartford Climate Opportunities Y
Price$17.32
Change-$0.13 (-0.74%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$66.87
Change-$0.15 (-0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HEOYX vs RWIBX Comparison Chart
Loading...
VS
HEOYX vs. RWIBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HEOYX is a StrongBuy and RWIBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 128B vs. HEOYX (139M). RWIBX pays higher dividends than HEOYX: RWIBX (1.05) vs HEOYX (0.72). HEOYX was incepted earlier than RWIBX: HEOYX (9 years) vs RWIBX (22 years). HEOYX is a more actively managed with annual turnover of: 75.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than HEOYX: RWIBX (250) vs HEOYX (250000). RWIBX annual gain was more profitable for investors over the last year : 23.75 vs. HEOYX (21.54). HEOYX return over 5 years is better than : 69.56 vs. RWIBX (42.68).
HEOYXRWIBXHEOYX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD12.54113.56292%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets139M128B0%
Annual Yield % from dividends0.721.0568%
Returns for 1 year21.5423.7591%
Returns for 3 years0.817.3711%
Returns for 5 years69.5642.68163%
Returns for 10 yearsN/A49.04-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.940.75
+17.90%
Genfit SA
NNI112.94-2.01
-1.75%
Nelnet
ILMN131.14-3.25
-2.42%
Illumina
SPRB0.44-0.01
-2.59%
Spruce Biosciences
APLT7.70-0.30
-3.75%
Applied Therapeutics